CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 15 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $21,273,000 | -5.5% | 29,945,000 | 0.0% | 0.02% | +17.6% |
| Q1 2022 | $22,509,000 | +10.6% | 29,945,000 | 0.0% | 0.02% | +21.4% |
| Q4 2021 | $20,344,000 | -7.5% | 29,945,000 | 0.0% | 0.01% | -17.6% |
| Q3 2021 | $21,997,000 | -1.3% | 29,945,000 | 0.0% | 0.02% | -10.5% |
| Q2 2021 | $22,279,000 | -2.1% | 29,945,000 | 0.0% | 0.02% | -13.6% |
| Q1 2021 | $22,766,000 | +8.2% | 29,945,000 | 0.0% | 0.02% | +4.8% |
| Q4 2020 | $21,044,000 | +0.4% | 29,945,000 | 0.0% | 0.02% | -12.5% |
| Q3 2020 | $20,958,000 | +15.7% | 29,945,000 | 0.0% | 0.02% | +14.3% |
| Q2 2020 | $18,116,000 | -4.4% | 29,945,000 | 0.0% | 0.02% | -16.0% |
| Q1 2020 | $18,950,000 | -17.8% | 29,945,000 | -16.5% | 0.02% | +19.0% |
| Q4 2019 | $23,054,000 | +41.0% | 35,880,000 | 0.0% | 0.02% | +31.2% |
| Q3 2019 | $16,353,000 | -26.8% | 35,880,000 | 0.0% | 0.02% | -23.8% |
| Q2 2019 | $22,336,000 | -20.3% | 35,880,000 | 0.0% | 0.02% | -25.0% |
| Q1 2019 | $28,009,000 | +10.3% | 35,880,000 | 0.0% | 0.03% | 0.0% |
| Q4 2018 | $25,391,000 | -8.8% | 35,880,000 | 0.0% | 0.03% | +12.0% |
| Q3 2018 | $27,845,000 | -29.5% | 35,880,000 | -16.6% | 0.02% | -34.2% |
| Q2 2018 | $39,498,000 | – | 43,000,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|